Rebière, V., et al.. Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 Cm, Meningeal Lymphomatosis, and Interim PET Δsuvmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-free Survival and Overall Survival in Diffuse Large B-cell Lymphoma. Frontiers Media SA, Apr. 2022, doi:10.3389/fnume.2022.829138.